Prognosis30-40% responds to therapy with normalization of AST/ALT, seroconversion to AntiHBe and later on development of AntiHBs. Relapses are known but less in seroco..
This page is restricted. Please Login / Register to view this page.
Prognosis30-40% responds to therapy with normalization of AST/ALT, seroconversion to AntiHBe and later on development of AntiHBs. Relapses are known but less in seroco..
This page is restricted. Please Login / Register to view this page.
Prognosis30-40% responds to therapy with normalization of AST/ALT, seroconversion to AntiHBe and later on development of AntiHBs. Relapses are known but less in seroco..
This page is restricted. Please Login / Register to view this page.
Prognosis30-40% responds to therapy with normalization of AST/ALT, seroconversion to AntiHBe and later on development of AntiHBs. Relapses are known but less in seroco..
This page is restricted. Please Login / Register to view this page.
Prognosis30-40% responds to therapy with normalization of AST/ALT, seroconversion to AntiHBe and later on development of AntiHBs. Relapses are known but less in seroco..
This page is restricted. Please Login / Register to view this page.
Prognosis30-40% responds to therapy with normalization of AST/ALT, seroconversion to AntiHBe and later on development of AntiHBs. Relapses are known but less in seroco..
This page is restricted. Please Login / Register to view this page.
Prognosis30-40% responds to therapy with normalization of AST/ALT, seroconversion to AntiHBe and later on development of AntiHBs. Relapses are known but less in seroco..
This page is restricted. Please Login / Register to view this page.